Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
certolizumab pegol (cimzia) (2 trials)
Crohn Disease (Phase 4)
Trials (2 total)
Trial APIs (1 total)